Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AskRx vs MEDVidi

AskRx
Graded #430

Lower grade

vs+2.200000000000003
MEDVidi
Graded #384

Higher grade

The verdict

MEDVidi takes it — 58/100 to 55.8/100.

MEDVidi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide), plus…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMEDVidi +21
24
45
Dose & formulationAskRx +14
67
53
Clinical oversightAskRx +5
82
77
Labs & monitoringMEDVidi +10
52
62
FulfillmentAskRx +29
88
59
Contract termsMEDVidi +35
20
55
AskRx · left barMEDVidi · right bar

The numbers

MetricAskRxMEDVidi
WeighScore55.8/10058/100
GradeCC
Scorecard rank#430#384
Semaglutide$349/mo (all doses, brand-name)Not disclosed
Tirzepatide$299/mo (2.5 mg dose, brand-name)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
AskRx

Graded #430 · C

Strengths

  • Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
  • LegitScript approved and HIPAA compliant
  • Board-certified physicians trained in obesity medicine
  • Transparent dose-based pricing published on site
  • Available in all 50 states

Where it loses points

  • Cash-pay model; medication cost billed separately by the pharmacy
  • Does not dispense medication itself, so fulfillment depends on third-party pharmacies
  • No compounded lower-cost alternative offered
  • Specific list of supported states is not published
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard